{"id":148428,"date":"2025-06-08T19:56:22","date_gmt":"2025-06-08T19:56:22","guid":{"rendered":"https:\/\/teknomers.com\/en\/a-new-score-incorporating-hepatitis-b-to-effectively-predict-risks-finally-teknomers\/"},"modified":"2025-06-08T19:56:24","modified_gmt":"2025-06-08T19:56:24","slug":"a-new-score-incorporating-hepatitis-b-to-effectively-predict-risks-finally-teknomers","status":"publish","type":"post","link":"https:\/\/teknomers.com\/en\/a-new-score-incorporating-hepatitis-b-to-effectively-predict-risks-finally-teknomers\/","title":{"rendered":"A new score incorporating hepatitis B to effectively predict risks finally! Teknomers."},"content":{"rendered":"\n
\n

Evaluating the risk for each patient to develop liver cancer remains a significant challenge today. In France, researchers have recently developed a predictive score that integrates hepatitis B as a major risk factor for this type of cancer.<\/strong><\/p>\n

Creating a More Easily Calculable Score<\/h2>\n

According to a 2022 publication from the United Nations<\/a>, over 900,000 individuals were newly diagnosed with liver cancer worldwide that year. Furthermore, over 830,000 patients lost their lives<\/strong> due to this disease. The number of new cases (and deaths) is expected to increase by more than 55% by 2040. The common origin of this infectious disease, specifically its most prevalent form\u2014hepatocellular carcinoma\u2014is none other than the hepatitis B virus (HBV)<\/a>.<\/p>\n

Anticipating such complications and organizing appropriate monitoring is possible. However, identifying the patients most at risk<\/strong> remains a daunting task. More than thirty already existing predictive scores aim to help evaluate the likelihood that a patient will or will not develop the disease, taking hepatitis B as a significant factor. However, most of these scores rely on biological data requiring complex analyses<\/strong>, such as searching for a genetic mutation or measuring a specific blood marker.<\/p>\n

In France, the National Institute of Health and Medical Research (INSERM) led a study that was published in the journal Liver International<\/a> on March 15, 2025. The objective? To design a score calculated from data available in the standard follow-up<\/strong> of patients with chronic hepatitis B.<\/p>\n

Credits: Mart production \/ Pexels<\/figcaption><\/figure>\n

For Early Risk Assessment<\/h2>\n

For their study needs, experts used data from the French cohort ANRS CO22 Hepather<\/a> (2012), aimed at evaluating the effectiveness of new treatments against viral hepatitis. While the cohort included approximately 20,000 individuals, INSERM researchers incorporated data from 4,370 patients affected by either hepatitis B and\/or C<\/strong>. Notably, 56 of these patients developed liver cancer during the eight years of follow-up in the cohort.<\/p>\n

Two scores emerged from this research: Adaptt and Sadaptt. The latter is essentially an improved version of the former. It includes six common factors<\/strong>: the patient’s age, co-infection with the Delta hepatitis virus (HDV), high-risk alcohol consumption, low platelet count, smoking level, and the presence of anti-HBV treatment. The Sadaptt version adds a seventh factor<\/strong>: the daily consumption of sodas.<\/p>\n

According to the leaders of this research, this new score should finally allow for a premature risk assessment for liver cancer<\/strong> in every patient with chronic hepatitis B. The next step involves developing tailored follow-ups and care, which may include specific recommendations such as reducing or ceasing smoking, alcohol, or sugary beverage consumption.<\/p>\n<\/div>\n


\n
General News – 2<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Evaluating the risk for each patient to develop liver cancer remains a significant challenge today. In France, researchers have recently developed a predictive score that integrates hepatitis B as a major risk factor for this type of cancer. Creating a More Easily Calculable Score According to a 2022 publication from the United Nations, over 900,000 […]<\/p>\n","protected":false},"author":1,"featured_media":148429,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36400],"tags":[],"class_list":["post-148428","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/posts\/148428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/comments?post=148428"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/posts\/148428\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/media\/148429"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/media?parent=148428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/categories?post=148428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/en\/wp-json\/wp\/v2\/tags?post=148428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}